In cardiovascular diseases, Bcl2L12 forms a complex with c-Myc in eosinophils (Eos) to inhibit FasL expression and confer apoptosis resistance of Eos in myocardial tissue [38]. Here, BCL2L12 is linked to cardiovascular disorder.